Compare ADMA Biologics Inc (ADMA) vs Extra Space Storage, Inc. (EXR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Extra Space Storage, Inc. — how do they compare? ADMA Biologics Inc trades at $9.23 (market cap $2.13B), while Extra Space Storage, Inc. trades at $144.92 (market cap $31.21B). The key difference: Extra Space Storage, Inc. is far larger — about 14.7× ADMA Biologics Inc's market cap, and Extra Space Storage, Inc. pays a 4.39% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | EXR | |
|---|---|---|
Market Cap | $2.13B | $31.21B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $152.75 |
52-Week Low | $7.60 | $126.67 |
Enterprise Value | $2.20B | $45.01B |
Dividend Yield | — | 4.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
EXR trades at $147.73, down 1.04% on the day, with a neutral technical signal and strong fundamentals including a 27.66% net income margin and consistent earnings beats. The company maintains robust cash flow from operations at $1.85B in 2025 and recently priced $550 million in senior notes. Analyst consensus is mixed with a $152.86 price target, while technical support sits at $144.
Outlook remains stable with revenue growth and dividend reliability, but risks include high leverage with a 46.63% debt-to-asset ratio and competitive pressures. The stock offers value near consensus targets, though margin compression and interest rate sensitivity warrant caution for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →
